Company intelligence

FDMT

4D Molecular Therapeutics, Inc. · NASDAQ · Healthcare

Price$10.80-8.86% · −$1.05

Market cap596.64MEquity value

P / E-4.2Trailing ratio

Volume996.1KLatest session

Market data

FDMT price chart

TradingView

Related signals

1 min delayed

Browse public FDMT signals with their source context and measured market impact. Open any signal for its permanent analysis page.

FDMTAug 1, 2025-5.32% since signal

4D Molecular Therapeutics Rallies On Heels Of Diabetes-Related Vision Study

FDMT shares up 20.6% after positive Spectra trial results. 4D-150 demonstrated significant improvement in visual acuity for DME patients. The drug shows 78% reduction in treatment burden compared to current standards. 4D-150 was well-tolerated with no significant safety concerns reported. Marketing authorization may soon follow due to regulatory agreement.

View signal analysis

Research